Original-Research: Rosenbauer International AG - from NuWays AG
Classification of NuWays AG to Rosenbauer International AG
Company Name: Rosenbauer International AG ISIN: AT0000922554
Reason for the research: Update
Recommendation: Kaufen
from: 21.05.2024
Target price: EUR 50.00
Target price on sight of: 12 Monaten
Last rating change:
Analyst: Christian Sandherr
Solid start into the year // record order backlog; chg. est.
Topic: Rosenbauer released solid Q1 figures with sales above but EBIT below our estimates. The demand for firefighting vehicles is unbroken supported by several structural trends, leading to a strong order intake and a new record high in order backlog.
Q1 sales grew by 17.7% yoy to € 226m (eNuW: € 215m) thanks to the company’s strong order backlog of € 1.79bn at the end of FY23 and an average price increase of 8% yoy per fire truck delivered in Q1. On a regional level, growth in the Europe (+67% yoy to € 106m) and the Americas area (+6.0% yoy to € 80m) compensated for a weaker Asia-Pacific (-51% yoy to € 12.4m) and Middle East & Africa area (-9.0% yoy to € 17.1m).
EBIT improved by € 5.2m yoy to € 0.3m (eNuW: € 4.4m) backed by further stabilization of supply chains but also substantial price increases. The reported EBIT includes a negative one-off effect of € 2.3m due to the departure of a member of the Executive Board and the realization of a new banking agreement. The fact that EBIT in the first quarter was positive for the first time in two years, despite negative one-offs, underpins the successful operational turnaround of the company.
Unbroken strong demand. Q1 order intake stood at € 362m (+24% yoy), implying a book-to-bill ratio of 1.6x. Coupled with the strong demand during the past quarters and supply chain issues, the group’s order backlog grew again to a new record high of € 1.94bn (+20% yoy). Rosenbauer intends to reduce the book-to-bill ratio to a level of 1x to decrease lead times and with that the implied risk in the order book of increases on the cost side like in FY21 & FY22.
FY guidance reiterated. For FY24e, management expects sales of € 1.2bn (+ 12.7% yoy) and an EBIT margin of 5%. While we are slightly more cautious (eNuW: Sales € 1.18bn, EBIT margin 4.7%), we expect further sequential improvements throughout FY24e after the transition year FY23. FY24e should benefit from (1) price increases which are successively reflected in sales (2) a further improving supply chain and (3) internal efficiency measures.
As the supply chain situation further improves and with a record high in order backlog, shares look poised for a re-rating. Reiterate BUY with an unchanged € 50.00 PT based on DCF.
You can download the research here:
http://www.more-ir.de/d/29823.pdf
For additional information visit our website
www.nuways-ag.com/research.
Contact for questions
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++
-------------------transmitted by EQS Group AG.-------------------
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.